Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.25 USD | -0.64% | +17.26% | +27.81% |
May. 17 | Oppenheimer Initiates Capricor Therapeutics at Outperform Rating | MT |
May. 13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.81% | 197M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.73% | 21.97B | |
-4.73% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Insider Sell: Capricor Therapeutics